June 17, 2020 / 11:50 AM / 22 days ago

Germany not planning to take further biotech stakes after CureVac move - Scholz

BERLIN (Reuters) - Germany is not currently planning to take any further stakes in biotech firms, Finance Minister Olaf Scholz said on Wednesday after Berlin announced it would take a stake in German vaccine developer CureVac.

“We don’t have a strategic plan for this now,” Scholz told a news conference to present the government’s second supplementary budget to finance its stimulus package.

Germany announced plans on Monday to take a stake of about 23% in unlisted biotech firm CureVac by backing a 300 million euro ($337 million) capital increase to fund the company’s further development of a COVID-19 vaccine.

Reporting by Michael Nienaber; Editing by Michelle Martin

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below